Hailiang Huang
Papers
1
Total Citations
8
H-Index
1
About
Dr. Hailiang Huang is a leading researcher in the genetic determinants of infectious disease susceptibility, with a particular focus on hepatitis B virus (HBV) infection and its severe complications. His work bridges immunogenetics and clinical hepatology to uncover why some patients develop life-threatening outcomes. In his landmark 2018 study, Dr. Huang identified that a host genetic variant in the *CXCL16* gene may be significantly associated with HBV-related acute liver failure—a rare but devastating condition. This finding, which has garnered 8 citations, provides critical insight into the chemokine signaling pathways that drive immune-mediated liver damage. By linking a specific genetic polymorphism to disease severity, his research offers a potential biomarker for early risk stratification and a target for therapeutic intervention. Dr. Huang’s contributions are particularly impactful given that HBV affects approximately 250 million people worldwide, with acute liver failure representing a major cause of mortality. His work exemplifies how precision genomics can illuminate the mechanisms of infectious disease pathogenesis, paving the way for personalized approaches to prevention and treatment in high-risk populations.
Research Focus
Key Achievements
Top Papers
- 1